In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Creative Medical Technology Holdings Inc. (OTCMKTS:CELZ) reported that Warbington Timothy has picked up 65,114,994 of common stock as of 2017-05-18.
The acquisition brings the aggregate amount owned by Warbington Timothy to a total of 65,114,994 representing less than 61.3% stake in the company.
For those not familiar with the company, Creative Medical Technology Holdings, Inc., formerly Jolley Marketing, Inc., is a clinical-stage company. The Company conducts its business operations primarily through its subsidiary, Creative Medical Technologies, Inc. (CMT). The Company is engaged in stem cell research and applications for use to treat male and female sexual dysfunction, infertility, miscarriages and related issues. CMT focuses on completing the testing of its erectile dysfunction (ED) treatment and, if warranted, marketing treatment kits under the name Caverstem to physicians for use with their patients suffering from ED. CMT also intends to test and, if warranted, market licensed stem cell products under its infertility technology license. Procedures for use of the Company’s ED stem cell treatment consist of a one-hour out-patient visit in a physician’s office. The physician would harvest a patient’s bone marrow from the hip using local anesthetic and separate the stem cells using a cell separator.
A glance at Creative Medical Technology Holdings Inc. (OTCMKTS:CELZ)’s key stats reveals a current market capitalization of 51.91 Million based on 106.26 Million shares outstanding and a price at last close of $0.488 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-12-02, Herbst picked up 1,000,000 at a purchase price of $0.10. This brings their total holding to 11,346,667 as of the date of the filing.
On the sell side, the most recent transaction saw Warbington unload 2,935,609 shares at a sale price of $0.10. This brings their total holding to 58,618,267.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Creative Medical Technology Holdings Inc. (OTCMKTS:CELZ) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.